UNBELIEVABLE: 50 - The Untold Story

Government suing PPE Medpro because of ‘buyer’s remorse’, court told

The Department of Health and Social Care wants PPE Medpro to repay more than £120 million over an alleged breach of contract.

Evening Standard · Jul 8, 2025

Mustang Bio Stock Jumps 180% After FDA Grants Orphan Drug Status to Brain Cancer Drug

Mustang Bio stock surged over 180% on Monday after the FDA granted its brain cancer drug candidate an orphan drug designation.

International Business Times UK · Jul 8, 2025

Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket

Shares of ENDRA Life Sciences Inc. (NASDAQ:NDRA) rose sharply in pre-market trading after the company announced it will be granted a US patent titled “Radio Frequency Applicator”.

Benzinga · Jul 8, 2025

MIRA Pharmaceuticals' Marijuana Analog Mira-55 Shows Potent Pain Relief In Preclinical Study, Stock Jumps 50% After Hours

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) shares soared to $1.87, an approximate 50.8% jump, during after-hours trading on Wednesday.

Benzinga · Jul 3, 2025

If AstraZeneca goes to the US, it will be a major blow for London and Labour

Move would deprive LSE of its biggest star and could topple a key pillar of the government’s industrial strategy

The Guardian - UK · Jul 2, 2025

Fears over £160bn blow to London’s stock market as AstraZeneca considers listing move to US

CEO Pascal Soriot has not hidden his annoyance at taxes and regulations the pharmaceutical firm have to navigate

The Independent UK · Jul 2, 2025

Federal Watchdog Slams CBP for Mismanaging Millions in Tech Aimed To Detect Fentanyl at Border

A report found that of 361 systems installed since 2019, 166 (46%) were inoperable at some point, sometimes for as long as 344 days, resulting in more than 400,000 hours of downtime

Latin Times · Jun 30, 2025

Biotech Catalyst Alert: NKTR, CDTX & WGS Rallying With Big Gains

With major rallies and analyst backing, Nektar, Cidara, and GeneDx are drawing interest; will these biopharma firms maintain their growth trajectories?

MarketBeat · Jun 30, 2025

Risk to patient health from drug shortages is ‘distressing new normal’

Medicine shortages are causing unprecedented issues for patients, Community Pharmacy England said.

Evening Standard · Jun 29, 2025

3 Biotech Stocks to Watch: Iovance, Neurocrine & Viking

Timing matters with biotech stocks; these three companies offer distinct risk-reward profiles but have upcoming catalysts that could redefine their value

MarketBeat · Jun 29, 2025